EAM
Empirical Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-407
| Closed | -$392K | – | 379 |
|
|
2024
Q1 | $392K | Buy |
407
+61
| +18% | +$58.7K | 0.19% | 154 |
|
|
2023
Q4 | $304K | Sell |
346
-749
| -68% | -$658K | 0.25% | 134 |
|
|
2023
Q3 | $901K | Buy |
1,095
+110
| +11% | +$90.5K | 0.79% | 33 |
|
|
2023
Q2 | $708K | Buy |
985
+55
| +6% | +$39.5K | 0.63% | 53 |
|
|
2023
Q1 | $764K | Buy |
930
+237
| +34% | +$195K | 0.73% | 46 |
|
|
2022
Q4 | $500K | Sell |
693
-339
| -33% | -$245K | 0.53% | 76 |
|
|
2022
Q3 | $711K | Buy |
1,032
+348
| +51% | +$240K | 0.78% | 38 |
|
|
2022
Q2 | $404K | Buy |
+684
| New | +$404K | 0.43% | 84 |
|